Skip to content

Clinical trials

Completed Breast Neoplasms trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: South Africa Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20037
20048
20067
20073
20083
20097
20101
20114
20125
20134
20142
20182
20193
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche14
Novartis Pharmaceuticals11
ETOP IBCSG Partners Foundation7
Sanofi6
AstraZeneca4
Pfizer3
Amgen2
Eisai Inc.2
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms75
Neoplasm Metastasis9
Neoplasms3
Osteoporosis2
Triple Negative Breast Neoplasms2
Anemia1
Bone Diseases, Metabolic1
Breast Diseases1
Hereditary Sensory and Autonomic Neuropathies1
Infertility1

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.